SIC 2833 – Medicinal Chemicals and Botanical Products
Valuation | |
---|---|
Market Cap ($M) | 441.71 |
Enterprise Value ($M) | 491.20 |
Book Value ($M) | 2,702.10 |
Book Value / Share | 2.70 |
Price / Book | 0.16 |
NCAV ($M) | -14.75 |
NCAV / Share | -0.01 |
Price / NCAV | -29.94 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.31 |
Return on Assets (ROA) | -0.22 |
Return on Equity (ROE) | -0.28 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.61 |
Current Ratio | 2.62 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 686.29 |
Assets | 3,403.15 |
Liabilities | 701.04 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
8,817,532 | 21,625,312 | 40.77 | |
4,359,314 | 12,034,453 | 36.22 | |
10,777,916 | 23,199,443 | 46.46 | |
9,454,731 | 19,665,631 | 48.08 | |
(click for more detail) |
Similar Companies | |
---|---|
TARS – Tarsus Pharmaceuticals, Inc. | TECH – Bio-Techne Corporation |
TERN – Terns Pharmaceuticals, Inc. | TNYA – Tenaya Therapeutics, Inc. |
TRML – Tourmaline Bio, Inc. |
Financial data and stock pages provided by
Fintel.io